Filter
964
Text search:
drug-resistance
infections
Featured
Recommendations
102
New Publications
287
Language
Document type
No document type
634
Studies & Reports
129
Guidelines
123
Manuals
26
Strategic & Response Plan
23
Fact sheets
10
Training Material
9
Situation Updates
6
Infographics
4
Countries / Regions
India
54
Ethiopia
28
South Africa
28
Tanzania
27
Western and Central Europe
26
Nepal
25
Kenya
24
Eastern Europe
19
Zambia
18
Malawi
18
Africa
18
Uganda
15
Namibia
15
Asia
15
Nigeria
14
Ghana
14
Cambodia
13
Sierra Leone
11
Liberia
11
Rwanda
10
Lesotho
10
Latin America and the Carribbean
10
Russia
10
Zimbabwe
9
Bangladesh
9
Myanmar / Burma
9
South–East Asia Region
8
Ukraine
7
Global
7
Philippines
6
Botswana
6
Senegal
5
Cameroon
5
Pakistan
5
Eswatini/ Swaziland
5
Mozambique
4
East and Southern Africa
4
Albania
4
Burkina Faso
3
Indonesia
3
West and Central Africa
3
Middle East and North Africa
3
Venezuela
3
Vietnam
3
Guinea
2
Haiti
2
Afghanistan
2
Thailand
2
China
2
Sri Lanka
2
Western Pacific Region
2
Laos
2
Georgia
2
Gabon
2
Congo, Democratic Republic of
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
South Sudan
1
Iraq
1
Jordan
1
Lebanon
1
Egypt
1
Gambia
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Brazil
1
Serbia
1
Eastern Europe and Central Asia
1
Paraguay
1
Bhutan
1
Armenia
1
Timor Leste/ East Timor
1
Tajikistan
1
Estonia
1
Iran
1
Turkmenistan
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
359
Clinical Guidelines
109
Public Health
30
Women & Child Health
21
Pharmacy & Technologies
17
Capacity Building
8
Key Resources
7
Toolboxes
TB
191
HIV
188
AMR
143
NTDs
23
Pharmacy
17
Planetary Health
12
Polio
9
Ebola
8
Global Health Education
8
Rapid Response
7
Refugee
7
Caregiver
7
COVID-19
6
Natural Hazards
3
Mental Health
3
Health Financing Toolbox
3
NCDs
3
Cholera
2
Conflict
2
Disability
1
Zika
1
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of
...
The National Strategic Plan for HIV/AIDS and STIs 2017-2024 spells out the objectives and targets that we have jointly committed to achieve. The plan describes the strategies and activities that will need to be implemented on the ground across India's 36 States and Union Territories with the help of
...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i
...
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There
...
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tuberculosis, acute respiratory
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h
...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel
...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread,
...
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections
...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread
...
J Glob Health Sci. 2020 Jun;2(1):e3. A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most
...
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug
...
Antimicrobials are medicines, including antibiotics, antivirals, antifungals, and antiparasitics, that are used to prevent and treat infections in humans, animals, and plants. Antimicrobial Resistance (AMR) arises when bacteria, viruses, fungi, and
...
The goal of this addendum is to help management and staff
minimize the risk of TB transmission at facilities in resource limited settings in which a.) HIV-infected persons receive diagnosis, care, treatment,
and/or support, and b.) there is a high prevalence of HIV infection, both known
and
...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi
...
During the implementation of the National Strategic Plan 2009–2012 on HIV and AIDS, Rwanda has continued its progress towards universal access to HIV and AIDS services. The new HIV and AIDS National Strategic Plan July 2013–June 2018 (thereafter referred to as ‘the NSP’) presented here is se
...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul ...
Migrants and mobile popul ...
The purpose of the PAS III is to guide Pakistan’s overall national response for HIV and AIDS through 2020, through focused interventions with set targets, costs, roles and responsibilities. The successful implementation of PAS III involves multiple stakeholders to achieve priority outcomes outline
...
The toolkit is a collection of assessment tools and checklists that describe the key considerations to be taken into account when transitioning to Option B/B+. The toolkit provides a roadmap to support the planning and implementation of Option B/B+, and to help countries scale up more effective inte
...
